Cargando…

Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering

Sucrose acetate isobutyrate (SAIB) is a sugar-based carrier. We have previously applied SAIB as a minimally invasive system for the co-delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) and found synergy when co-delivering zoledronic acid (ZA) and hydroxyapatite (HA) nanoparticles....

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tegan L, Murphy, Ciara M, Ravarian, Roya, Dehghani, Fariba, Little, David G, Schindeler, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669987/
https://www.ncbi.nlm.nih.gov/pubmed/26668709
http://dx.doi.org/10.1177/2041731415609448
_version_ 1782404197348540416
author Cheng, Tegan L
Murphy, Ciara M
Ravarian, Roya
Dehghani, Fariba
Little, David G
Schindeler, Aaron
author_facet Cheng, Tegan L
Murphy, Ciara M
Ravarian, Roya
Dehghani, Fariba
Little, David G
Schindeler, Aaron
author_sort Cheng, Tegan L
collection PubMed
description Sucrose acetate isobutyrate (SAIB) is a sugar-based carrier. We have previously applied SAIB as a minimally invasive system for the co-delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) and found synergy when co-delivering zoledronic acid (ZA) and hydroxyapatite (HA) nanoparticles. Alternative bioceramics were investigated in a murine SAIB/rhBMP-2 injection model. Neither beta-tricalcium phosphate (TCP) nor Bioglass (BG) 45S5 had a significant effect on bone volume (BV) alone or in combination with the ZA. (14)C-labelled ZA binding assays showed particle size and ceramic composition affected binding with nano-HA > micro-HA > TCP > BG. Micro-HA and nano-HA increased BV in a rat model of rhBMP-2/SAIB injection (+278% and +337%), and BV was further increased with ZA–adsorbed micro-HA and nano-HA (+530% and +889%). These data support the use of ZA–adsorbed nanoparticle-sized HA as an optimal additive for the SAIB/rhBMP-2 injectable system for bone tissue engineering.
format Online
Article
Text
id pubmed-4669987
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-46699872015-12-14 Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering Cheng, Tegan L Murphy, Ciara M Ravarian, Roya Dehghani, Fariba Little, David G Schindeler, Aaron J Tissue Eng Original Article Sucrose acetate isobutyrate (SAIB) is a sugar-based carrier. We have previously applied SAIB as a minimally invasive system for the co-delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) and found synergy when co-delivering zoledronic acid (ZA) and hydroxyapatite (HA) nanoparticles. Alternative bioceramics were investigated in a murine SAIB/rhBMP-2 injection model. Neither beta-tricalcium phosphate (TCP) nor Bioglass (BG) 45S5 had a significant effect on bone volume (BV) alone or in combination with the ZA. (14)C-labelled ZA binding assays showed particle size and ceramic composition affected binding with nano-HA > micro-HA > TCP > BG. Micro-HA and nano-HA increased BV in a rat model of rhBMP-2/SAIB injection (+278% and +337%), and BV was further increased with ZA–adsorbed micro-HA and nano-HA (+530% and +889%). These data support the use of ZA–adsorbed nanoparticle-sized HA as an optimal additive for the SAIB/rhBMP-2 injectable system for bone tissue engineering. SAGE Publications 2015-10-22 /pmc/articles/PMC4669987/ /pubmed/26668709 http://dx.doi.org/10.1177/2041731415609448 Text en © The Author(s) 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Cheng, Tegan L
Murphy, Ciara M
Ravarian, Roya
Dehghani, Fariba
Little, David G
Schindeler, Aaron
Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
title Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
title_full Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
title_fullStr Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
title_full_unstemmed Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
title_short Bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
title_sort bisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineering
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669987/
https://www.ncbi.nlm.nih.gov/pubmed/26668709
http://dx.doi.org/10.1177/2041731415609448
work_keys_str_mv AT chengteganl bisphosphonateadsorbedceramicnanoparticlesincreaseboneformationinaninjectablecarrierforbonetissueengineering
AT murphyciaram bisphosphonateadsorbedceramicnanoparticlesincreaseboneformationinaninjectablecarrierforbonetissueengineering
AT ravarianroya bisphosphonateadsorbedceramicnanoparticlesincreaseboneformationinaninjectablecarrierforbonetissueengineering
AT dehghanifariba bisphosphonateadsorbedceramicnanoparticlesincreaseboneformationinaninjectablecarrierforbonetissueengineering
AT littledavidg bisphosphonateadsorbedceramicnanoparticlesincreaseboneformationinaninjectablecarrierforbonetissueengineering
AT schindeleraaron bisphosphonateadsorbedceramicnanoparticlesincreaseboneformationinaninjectablecarrierforbonetissueengineering